Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant <i>Pseudomonas aeruginosa</i> Infections in Neutropenic Patients

Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant <i>Pseudomonas aeruginosa</i> Infections in Neutropenic Patients

The effectiveness of ceftolozane/tazobactam for the treatment of infections in neutropenic patients caused by hypervirulent multidrug-resistant (MDR) <i>Pseudomonas aeruginosa</i> has not been previously reported. We identified seven cases of MDR <i>P. aeruginosa</i> infectio...

Full description

Bibliographic Details
Main Authors: Paolo E. Coppola, Paolo Gaibani, Chiara Sartor, Simone Ambretti, Russell E. Lewis, Claudia Sassi, Marco Pignatti, Stefania Paolini, Antonio Curti, Fausto Castagnetti, Margherita Ursi, Michele Cavo, Marta Stanzani
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Microorganisms
Subjects:
<i>Pseudomonas aeruginosa</i>
ceftolozane/tazobactam
hypervirulent
skin and soft tissue
neutropenia
hematological malignancy
Online Access:https://www.mdpi.com/2076-2607/8/12/2055

Internet

https://www.mdpi.com/2076-2607/8/12/2055

Similar Items